7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Body Weight D001835 333 associated lipids
Lung Neoplasms D008175 171 associated lipids
Adenocarcinoma D000230 166 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Inflammation D007249 119 associated lipids
Hypertension D006973 115 associated lipids
Glioma D005910 112 associated lipids
Weight Gain D015430 101 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
pmid:26112994
pmid:26099662
Yu SG et al. Ursolic acid derivative ameliorates streptozotocin-induced diabestic bone deleterious effects in mice. 2015 Int J Clin Exp Pathol pmid:26097549
pmid:26096594
Schmitz F et al. Repurposing an Osteoporosis Drug for β Cell Regeneration in Diabetic Patients. 2015 Cell Metab. pmid:26094892
Kondegowda NG et al. Osteoprotegerin and Denosumab Stimulate Human Beta Cell Proliferation through Inhibition of the Receptor Activator of NF-κB Ligand Pathway. 2015 Cell Metab. pmid:26094891
Telejko B et al. The association of bone turnover markers with pro- and anti-inflammatory adipokines in patients with gestational diabetes. 2015 Ann Agric Environ Med pmid:26094529
pmid:26093292
pmid:26092508
Ketlogetswe KS et al. Osteoprotegerin, but Not Receptor Activator for Nuclear Factor-κB Ligand, is Associated With Subclinical Coronary Atherosclerosis in HIV-Infected Men. 2015 J. Acquir. Immune Defic. Syndr. pmid:26090754
Pietschmann P et al. Immunology of Osteoporosis: A Mini-Review. 2016 Gerontology pmid:26088283
Burton LJ et al. Muscadine grape skin extract can antagonize Snail-cathepsin L-mediated invasion, migration and osteoclastogenesis in prostate and breast cancer cells. 2015 Carcinogenesis pmid:26069256
pmid:26069065
Collins FL et al. Death Receptor 3 (TNFRSF25) Increases Mineral Apposition by Osteoblasts and Region Specific New Bone Formation in the Axial Skeleton of Male DBA/1 Mice. 2015 J Immunol Res pmid:26065008
Zavala-Cerna MG et al. Osteoprotegerin Polymorphisms in a Mexican Population with Rheumatoid Arthritis and Generalized Osteoporosis: A Preliminary Report. 2015 J Immunol Res pmid:26065000
Davenport C et al. The Effects of Atorvastatin on Arterial Stiffness in Male Patients with Type 2 Diabetes. 2015 J Diabetes Res pmid:26064990
pmid:26062841
Rzepka R et al. Soluble receptors for advanced glycation end products and receptor activator of NF-κB ligand serum levels as markers of premature labor. 2015 BMC Pregnancy Childbirth pmid:26059227
pmid:26057821
Weichhaus M et al. Osteoprotegerin in breast cancer: beyond bone remodeling. 2015 Mol. Cancer pmid:26054853
Kastritis E et al. Osteoprotegerin is a significant prognostic factor for overall survival in patients with primary systemic amyloidosis independent of the Mayo staging. 2015 Blood Cancer J pmid:26047389
pmid:26044839
pmid:26044709
Kuroyanagi G et al. Resveratrol amplifies BMP-4-stimulated osteoprotegerin synthesis via p38 MAP kinase in osteoblasts. 2015 Mol Med Rep pmid:26044505
Janda K et al. Cardiovascular risk in chronic kidney disease patients: intima-media thickness predicts the incidence and severity of histologically assessed medial calcification in radial arteries. 2015 BMC Nephrol pmid:26037625
Davenport C et al. The effects of insulin and liraglutide on osteoprotegerin and vascular calcification in vitro and in patients with type 2 diabetes. 2015 Eur. J. Endocrinol. pmid:26036811
Harrison R et al. Acute bone response to whole body vibration in healthy pre-pubertal boys. 2015 J Musculoskelet Neuronal Interact pmid:26032203
Goyden J et al. The Effect of OSM on MC3T3-E1 Osteoblastic Cells in Simulated Microgravity with Radiation. 2015 PLoS ONE pmid:26030441
pmid:26025293
pmid:26018435
Beederman M et al. Osteoprotegerin deficiency results in disruption of posterofrontal suture closure in mice: implications in nonsyndromic craniosynostosis. 2015 Plast. Reconstr. Surg. pmid:26017615
pmid:26016944
Tanaka Y et al. [Mesenchymal stem cells for the treatment and repair of inflammatory arthritis]. 2015 Nihon Rinsho Meneki Gakkai Kaishi pmid:26016635
Liu G et al. Endoplasmic reticulum stress-mediated inflammatory signaling pathways within the osteolytic periosteum and interface membrane in particle-induced osteolysis. 2016 Cell Tissue Res. pmid:26004143
Priyadarshi S et al. Genetic association and altered gene expression of osteoprotegerin in otosclerosis patients. 2015 Ann. Hum. Genet. pmid:25998045
pmid:25982995
Yang Y et al. The Proteasome Inhibitor Carfilzomib Suppresses Parathyroid Hormone-induced Osteoclastogenesis through a RANKL-mediated Signaling Pathway. 2015 J. Biol. Chem. pmid:25979341
Ehlken C et al. Increased expression of angiogenic and inflammatory proteins in the vitreous of patients with ischemic central retinal vein occlusion. 2015 PLoS ONE pmid:25978399
pmid:25968958
pmid:25967665
pmid:25962765
Ardeshirpour L et al. OPG Treatment Prevents Bone Loss During Lactation But Does Not Affect Milk Production or Maternal Calcium Metabolism. 2015 Endocrinology pmid:25961842
pmid:25956608
pmid:25953955
pmid:25944420
Reveille JD Biomarkers for diagnosis, monitoring of progression, and treatment responses in ankylosing spondylitis and axial spondyloarthritis. 2015 Clin. Rheumatol. pmid:25939520
pmid:25934570
Bortolin RH et al. Protection against T1DM-Induced Bone Loss by Zinc Supplementation: Biomechanical, Histomorphometric, and Molecular Analyses in STZ-Induced Diabetic Rats. 2015 PLoS ONE pmid:25933189
pmid:25931273
pmid:25930677
pmid:25926255
pmid:25926154
pmid:25920618
pmid:25912212
pmid:25895663
Wei J et al. Effectiveness of combined salmon calcitonin and aspirin therapy for osteoporosis in ovariectomized rats. 2015 Mol Med Rep pmid:25891179
Su F et al. Enhancement of periodontal tissue regeneration by transplantation of osteoprotegerin-engineered periodontal ligament stem cells. 2015 Stem Cell Res Ther pmid:25888745
Shen Y et al. (5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway. 2015 BMC Complement Altern Med pmid:25887296
Duan P et al. Gene polymorphisms in RANKL/RANK/OPG pathway are associated with ages at menarche and natural menopause in Chinese women. 2015 BMC Womens Health pmid:25884698
pmid:25871861
pmid:25871826
pmid:25868799
pmid:25866993
pmid:25865548
Warren JT et al. Correlating RANK ligand/RANK binding kinetics with osteoclast formation and function. 2015 J. Cell. Biochem. pmid:25864714
pmid:25859979
Kim KR et al. 15-deoxy-δ12,14-prostaglandin j2 inhibits osteolytic breast cancer bone metastasis and estrogen deficiency-induced bone loss. 2015 PLoS ONE pmid:25859665
pmid:25857587
pmid:25854266
Wu C et al. Oxygen-sensing PHDs regulate bone homeostasis through the modulation of osteoprotegerin. 2015 Genes Dev. pmid:25846796
pmid:25845543
Åšwierkot J et al. Assessment of the Effect of Methotrexate Therapy on Bone Metabolism in Patients with Rheumatoid Arthritis. 2015 Arch. Immunol. Ther. Exp. (Warsz.) pmid:25837853
pmid:25837159
pmid:25825337
pmid:25819470
pmid:25818585
pmid:25818584
Hassan SH et al. Effect of periodontal surgery on osteoprotegerin levels in gingival crevicular fluid, saliva, and gingival tissues of chronic periodontitis patients. 2015 Dis. Markers pmid:25814780
pmid:25812671
Folestad A et al. Role of Wnt/β-catenin and RANKL/OPG in bone healing of diabetic Charcot arthropathy patients. 2015 Acta Orthop pmid:25811776
pmid:25810067
pmid:25808546
pmid:25797915
pmid:25796629
Sutton KM et al. The functions of the avian receptor activator of NF-κB ligand (RANKL) and its receptors, RANK and osteoprotegerin, are evolutionarily conserved. 2015 Dev. Comp. Immunol. pmid:25796577
pmid:25795427
Zheng Y et al. Mesenchymal dental pulp cells attenuate dentin resorption in homeostasis. 2015 J. Dent. Res. pmid:25762594
SaÄŸlam M et al. Effect of sumac extract on serum oxidative status, RANKL/OPG system and alveolar bone loss in experimental periodontitis in rats. 2015 Jan-Feb J Appl Oral Sci pmid:25760266
pmid:25756521
pmid:25748834
pmid:25744546
pmid:25744169
pmid:25741581
Tsuruda T Osteoprotegerin: osteo-vascular connection. 2015 J. Atheroscler. Thromb. pmid:25740050
pmid:25738879
Hung JY et al. Tricetin, a dietary flavonoid, suppresses benzo(a)pyrene‑induced human non‑small cell lung cancer bone metastasis. 2015 Int. J. Oncol. pmid:25738754
Shah M et al. Local origins impart conserved bone type-related differences in human osteoblast behaviour. 2015 Eur Cell Mater pmid:25738584
Alwood JS et al. Ionizing Radiation Stimulates Expression of Pro-Osteoclastogenic Genes in Marrow and Skeletal Tissue. 2015 J. Interferon Cytokine Res. pmid:25734366
Xiong L et al. Lrp4 in osteoblasts suppresses bone formation and promotes osteoclastogenesis and bone resorption. 2015 Proc. Natl. Acad. Sci. U.S.A. pmid:25733894
Qiao B et al. Human mesenchymal stem cells as delivery of osteoprotegerin gene: homing and therapeutic effect for osteosarcoma. 2015 Drug Des Devel Ther pmid:25733814

Table of Content